Citations

Clear

3138 citation(s) found for "Smith, AM".

Arthroscopic Repair of a Lateral Meniscus Oblique Radial Tear
Langhans, Mark T. , Smith, Patrick A. , Hevesi, Mario , Pan, Xuankang , Krych, Aaron J.

Mayo Clinic

Video Journal of Sports Medicine | April 16, 2024 | Volume: 4 | Issue: 2 | Pages: No page available

10.1177/26350254231212931 | PMID 40308979 Get It

Background: Lateral meniscal oblique radial tears (LMORTs) are the most common type of lateral meniscal tears and occur concomitantly with anterior cruciate ligament (ACL) tears in up to 12% of cases. Four types of LMORTs have been classified in the literature based on proximity to the meniscal root and extent of the tear. Type 1 and 2 LMORTs represent partial and complete posterior root tears less than 10 mm from the root insertion. Type 3 and 4 LMORTs are partial and complete posterior radial meniscus tears greater than 10 mm from the root insertion. Indications: Type 3 and 4 LMORTs can and should be addressed with an all-inside side-to-side repair at the time of ACL reconstruction. LMORTs that are not repaired at the time of ACL reconstruction can contribute to persistent instability and meniscal extrusion. Technique Description: Diagnostic arthroscopy is performed to evaluate the posterior aspects of both the medial and lateral meniscus. The medial leaflet is commonly flipped into the notch and scarred to ACL remnant. After identifying and isolating the medial leaflet, an arthroscopic suture passer is used to pass a suture from inferior to superior through the medial leaflet. A second suture is passed from inferior to superior through the lateral leaflet. This is used to shuttle the suture pass through the medial leaflet to the bottom of the meniscus, where it can be tied in a horizontal mattress fashion. The sutures are tied down with aide of an arthroscopic knot pusher. A second set of sutures is passed and used to shuttle a second suture that would be tied posterior to the first suture, again in a horizontal mattress fashion. This allows reduction of the fragments in apposition across the tear. Postoperatively, patients are allowed range of motion from 0° to 90° and to toe touch weightbearing for the first 4 weeks. Patients are advanced to weightbearing as tolerated at 5 weeks. Typical return to sport ranges from 6 to 9 months postoperatively. Results: Results have been published for 2-year outcomes of type 3 and 4 LMORT repairs and have demonstrated persistent improved patient-reported outcomes as well as healing rates that are greater than 80% and in some series approach nearly 100%. Discussion/Conclusion: Arthroscopic all-inside side-to-side surgical repair is a durable and reliable treatment option for patients presenting for ACL reconstruction with concomitant type 3 or 4 LMORT. Patient Consent Disclosure Statement: The author(s) attests that consent has been obtained from any patient(s) appearing in this publication. If the individual may be identifiable, the author(s) has included a statement of release or other written form of approval from the patient(s) with this submission for publication.
Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study
Siontis, Konstantinos C. , Wieczorek, Mikolaj A. , Maanja, Maren , Hodge, David O. , Kim, Hyung‐Kwan , Lee, Heesun , Lim, Jaehyun , Ariga, Rina, Mahmod, Masliza , Ackerman, Michael J. , Friedman, Paul A. , Raman, Betty , Mahmod, Masliza , Watkins, Hugh , Neubauer, Stefan , Windecker, Stephan , Ackerman, Michael J , Friedman, Paul A , Kim, Hyung-Kwan , Lee, Hyun‐Jung , Park, Chan Soon , Watkins, Hugh , Windecker, Stephan , Siontis, George C.M. , Gersh, Bernard J. , Attia, Zachi I. , Noseworthy, Peter A.

Mayo Clinic

European Heart Journal - Digital Health | April 13, 2024 | Volume: 5 | Issue: 4 | Pages: 416-426

10.1093/ehjdh/ztae029 | PMID 39081936 Get It

Abstract Aims Recently, deep learning artificial intelligence (AI) models have been trained to detect cardiovascular conditions, including hypertrophic cardiomyopathy (HCM), from the 12-lead electrocardiogram (ECG). In this external validation study, we sought to assess the performance of an AI-ECG algorithm for detecting HCM in diverse international cohorts. Methods and results A convolutional neural network-based AI-ECG algorithm was developed previously in a single-centre North American HCM cohort (Mayo Clinic). This algorithm was applied to the raw 12-lead ECG data of patients with HCM and non-HCM controls from three external cohorts (Bern, Switzerland; Oxford, UK; and Seoul, South Korea). The algorithm’s ability to distinguish HCM vs. non-HCM status from the ECG alone was examined. A total of 773 patients with HCM and 3867 non-HCM controls were included across three sites in the merged external validation cohort. The HCM study sample comprised 54.6% East Asian, 43.2% White, and 2.2% Black patients. Median AI-ECG probabilities of HCM were 85% for patients with HCM and 0.3% for controls (P < 0.001). Overall, the AI-ECG algorithm had an area under the receiver operating characteristic curve (AUC) of 0.922 [95% confidence interval (CI) 0.910–0.934], with diagnostic accuracy 86.9%, sensitivity 82.8%, and specificity 87.7% for HCM detection. In age- and sex-matched analysis (case–control ratio 1:2), the AUC was 0.921 (95% CI 0.909–0.934) with accuracy 88.5%, sensitivity 82.8%, and specificity 90.4%. Conclusion The AI-ECG algorithm determined HCM status from the 12-lead ECG with high accuracy in diverse international cohorts, providing evidence for external validity. The value of this algorithm in improving HCM detection in clinical practice and screening settings requires prospective evaluation.
68Ga-DOTATATE and 18F-FDG PET Imaging of a Rare Chordoid Meningioma With Intracranial Recurrence and Extracranial Metastases
Smith, Mathew V. , Lang, Harrison J., Donev, Kliment , Lang, Harrison , Bendok, Bernard R. , Yang, Ming

Mayo Clinic

Clinical Nuclear Medicine | April 10, 2024 | Volume: 49 | Issue: 7 | Pages: e354-e356

10.1097/rlu.0000000000005237 | PMID 38598744 Get It

Abstract Chordoid meningiomas, rare meningioma variants, are characterized by their histopathological features and clinical behavior resembling that of other chondroid/myxoid neoplasms. We present a case of pathology-proven chordoid meningioma imaged with both 68Ga-DOTATATE and 18F-FDG PET images during a complicated postoperative course with multiple episodes of local recurrence and, ultimately, extracranial metastasis. This case underscores the aggressive behavior of chordoid meningiomas while highlighting how molecular imaging plays an important role in clinical monitoring and guidance of management.
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101
Batchelor, Tracy T. , Giri, Sharmila, Ruppert, Amy S. , Geyer, Susan M. , Smith, Scott E. , Mohile, Nimish, Swinnen, Lode J., Friedberg, Jonathan W. , Kahl, Brad S. , Bartlett, Nancy L. , Cheson, Bruce D. , Wagner‐Johnston, Nina D. , Nayak, Lakshmi , Leonard, John P. , Rubenstein, James L. , Hsi, Eric D , Wagner-Johnston, Nina , Bartlett, Nancy L , Kahl, Brad S , Hsi, Eric D.

Mayo Clinic

Blood Advances | April 10, 2024 | Volume: 8 | Issue: 12 | Pages: 3189-3199

10.1182/bloodadvances.2023011657 | PMID 38598710 Get It

Abstract Although it is evident that standard-dose whole-brain radiotherapy as consolidation is associated with significant neurotoxicity, the optimal consolidative strategy for primary central nervous system lymphoma (PCNSL) is not defined. We performed a randomized phase 2 clinical trial via the US Alliance cancer cooperative group to compare myeloablative consolidation supported by autologous stem cell transplantation with nonmyeloablative consolidation after induction therapy for PCNSL. To our knowledge, this is the first randomized trial to be initiated that eliminates whole-brain radiotherapy as a consolidative approach in newly diagnosed PCNSL. Patients aged 18 to 75 years were randomly assigned in a 1:1 manner to induction therapy (methotrexate, temozolomide, rituximab, and cytarabine) followed by consolidation with either thiotepa plus carmustine and autologous stem cell rescue vs induction followed by nonmyeloablative, infusional etoposide plus cytarabine. The primary end point was progression-free survival (PFS). A total of 113 patients were randomized, and 108 (54 in each arm) were evaluable. More patients in the nonmyeloablative arm experienced progressive disease or death during induction (28% vs 11%; P = .05). Thirty-six patients received autologous stem cell transplant, and 34 received nonmyeloablative consolidation. The estimated 2-year PFS was higher in the myeloablative vs nonmyeloablative arm (73% vs 51%; P = .02). However, a planned secondary analysis, landmarked at start of the consolidation, revealed that the estimated 2-year PFS in those who completed consolidation therapy was not significantly different between the arms (86% vs 71%; P = .21). Both consolidative strategies yielded encouraging efficacy and similar toxicity profiles. This trial was registered at www.clininicals.gov as #NCT01511562.
Association of Cytokine Proteins with Disease Activity in Neuromyelitis Optica Spectrum Disorder Participants Receiving Inebilizumab Treatment (S32.005)
Aktaş, Orhan , Kim, Ho Jin , Marignier, Romain , Wingerchuk, Dean M. , Smith, M. J. H., Rees, William A. , Patterson, Kristina, Pittock, Sean J. , Smith, Micheal, Clarkson, Kristen A. , Patterson, Kristina R. , Cree, Bruce

Mayo Clinic

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000204694 Get It

Effects of Gender on Neurology Career Outcomes (S39.010)
Schipani, Elke , Driver‐Dunckley, Erika , Mauricio, Elizabeth A. , Coon, Elizabeth A. , Mauricio, Elizabeth A. , Jones, Lyell K. , Smith, Kelsey M.

Mayo Clinic

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000204609 Get It

Ictal Whistling During Stereoelectroencephalography; An Unusual Vocalization of Mesial Temporal Involvement (P3-1.005)
Farooqi, Ashar , Lagerlund, Terrence D., Miller, Kai J. , Smith, Kelsey , Wong‐Kisiel, Lily C. , Smith, Kelsey

Mayo Clinic

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206073 Get It

Epilepsy with Eyelid Myoclonia Associated with CHD2 Variants: Report of Two Cases (P7-1.002)
Padilla, Hannah, Lanpher, Brendan C. , Smith, Kelsey , Wirrell, Elaine , Wong‐Kisiel, Lily C. , Fine, Anthony L. , Smith, Kelsey

Mayo Clinic

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000205794 Get It

Vagus Nerve Stimulation for Epilepsy During Pregnancy (P7-1.012)
Vu, Anhmai , Razaq, Aisha Abdul, Tatum, William O. , Drees, Cornelia , Szymanski, Linda M. , Britton, Jeffrey W. , Drees, Cornelia , Coon, Elizabeth A. , Lundstrom, Brian N. , Smith, Kelsey M.

Mayo Clinic

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000205667 Get It